• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Dividend Appeal Lacking in Abbott Split-Up

    The newly public AbbVie's dividend will be too concentrated to a single drug, while the payout from the remaining Abbott entity won't be as generous as in years past, according to Morningstar's Josh Peters.

  2. A Bond Pick That Could Deliver

    Washington Post's bonds could get a boost once some of the murkiness hanging over for-profit education and its Kaplan unit is cleared up.

  3. RS' Wolf: For-Profit Education Stocks Pass the Test

    Even after working through the impact of impending regulations, valuations for the for-profit educators are far higher than where they are trading today, says RS Investments manager Joe Wolf.

  4. Market Mis-Grading Apollo's Prospects

    Morningstar analyst Todd Young educates investors on why the market is underappreciating for-profit education company Apollo Group.

1
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.